RNO 0.00% 4.0¢ rhinomed limited

MUTE is truly disruptive

  1. 8,736 Posts.
    lightbulb Created with Sketch. 105
    Sensational trial results of Mute, a clean sweep of regulartory approvals and commercial release of Mute online!
    So whats next ????? A clue is in the AGM presentation by Michael Johnson. The new program for 2015 is looking extraordinarily exciting with some truly disruptive and attention attracting ideas being developed. Pleasingly when you look at the trial results it is abundantly clear that this technology truly delivers a material benefit to people . It really does change the lives of people who wear it. Not only does it reduce snoring-significantly- it also radically improves the sleep quality of people who wear it and their bed partners. It looks like we can look forward to distribution of Mute in pharmacies globally. Breathe right already has sales greater than $150 million . New trial shows superiority over Breathe Right.
    Mute will be tested along side other sleep apnea gold standard trial with Monash University early 2015 so this means that it can be used in conjunction with a cpap mask like what Resmed sells if these trial are successful.
    Mute can be set up with wearable tech for measurement of sleeping and breathing. Think integration of fitbit or apple iphone with a wearable tech version of Mute that monitors sleep and breathing.
    Nazal drug delivery trials by mid next year show a commercial evolution of sport adoption with the Turbine for sports and athletes such as Tour De France winner last year Chris Froome to breathe more snore less sleep version for Mute with great trial results. Now we will see the drug delivery version by mid next year which is worth hundreds of millions of dollars. Considerably higher than our current market capitalisation.
 
watchlist Created with Sketch. Add RNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.